当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析 - 现金流量表

以岭药业

(002603)

  

流通市值:206.72亿  总市值:250.94亿
流通股本:13.76亿   总股本:16.71亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,618,385,633.512,459,554,280.378,491,648,565.266,123,725,514.93
  收到的税费返还16,178,182.185,331,940.6217,835,975.0615,814,249.8
  收到其他与经营活动有关的现金110,039,771.2261,602,751.53285,518,572.42251,813,708.08
  经营活动现金流入小计4,744,603,586.912,526,488,972.528,795,003,112.746,391,353,472.81
  购买商品、接受劳务支付的现金1,305,466,933.8579,677,655.172,854,354,8552,122,582,744.32
  支付给职工以及为职工支付的现金976,401,208.71463,319,323.471,798,057,987.681,272,351,615.07
  支付的各项税费527,819,043.45357,741,531.49916,811,896.61619,939,181.53
  支付其他与经营活动有关的现金755,153,033.24515,040,647.861,449,269,994.981,098,240,962.85
  经营活动现金流出小计3,564,840,219.21,915,779,157.997,018,494,734.275,113,114,503.77
  经营活动产生的现金流量净额1,179,763,367.71610,709,814.531,776,508,378.471,278,238,969.04
二、投资活动产生的现金流量:
  收回投资收到的现金2,160,500,000810,000,0001,493,500,000893,000,000
  取得投资收益收到的现金12,068,603.744,679,962.94,078,192.991,473,331.58
  处置固定资产、无形资产和其他长期资产收回的现金净额--64,70041,637.17
  投资活动现金流入小计2,172,568,603.74814,679,962.91,497,642,892.99894,514,968.75
  购建固定资产、无形资产和其他长期资产支付的现金104,641,612.5154,183,825.3245,617,151.14172,041,905.95
  投资支付的现金2,660,000,0001,690,000,0002,254,000,0001,803,500,000
  投资活动现金流出小计2,764,641,612.511,744,183,825.32,499,617,151.141,975,541,905.95
  投资活动产生的现金流量净额-592,073,008.77-929,503,862.4-1,001,974,258.15-1,081,026,937.2
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金835,352,688-501,211,612.8-
  支付其他与筹资活动有关的现金5,433,348.512,320,329.2512,421,534.157,307,247.28
  筹资活动现金流出小计840,786,036.512,320,329.25513,633,146.957,307,247.28
  筹资活动产生的现金流量净额-840,786,036.51-2,320,329.25-513,633,146.95-7,307,247.28
四、汇率变动对现金及现金等价物的影响102,128.94274,475.71-812,591.14234,642.31
五、现金及现金等价物净增加额-252,993,548.63-320,839,901.41260,088,382.23190,139,426.87
  加:期初现金及现金等价物余额1,076,691,556.631,076,691,556.63816,603,174.4816,603,174.4
  期末现金及现金等价物余额823,698,008755,851,655.221,076,691,556.631,006,742,601.27
补充资料:
  净利润757,077,098.98-1,281,729,907.88-
  资产减值准备21,684,215.89-160,231,286.68-
  固定资产和投资性房地产折旧300,399,678.11-587,903,328.34-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧300,399,678.11-587,903,328.34-
  无形资产摊销21,485,572.19-28,827,746.3-
  长期待摊费用摊销1,439,618.58-3,085,129.48-
  处置固定资产、无形资产和其他长期资产的损失362,766.93-887,249.18-
  固定资产报废损失--1,091,974.1-
  公允价值变动损失-370,808.2--3,922,789.94-
  财务费用574,295.7-985,403.55-
  投资损失-12,062,259.52--4,067,615.92-
  递延所得税50,393,740.88-142,341,049.54-
  其中:递延所得税资产减少54,015,430.43-147,485,539.92-
    递延所得税负债增加-3,621,689.55--5,144,490.38-
  存货的减少-126,543,241.87-170,930,463.66-
  经营性应收项目的减少-255,895,491.74--169,202,249.83-
  经营性应付项目的增加416,561,656.73--416,869,787.4-
  其他---18,179,693.16-
  现金的期末余额823,698,008-1,076,691,556.63-
  减:现金的期初余额1,076,691,556.63-816,603,174.4-
  现金及现金等价物的净增加额-252,993,548.63-260,088,382.23-
公告日期2026-08-292026-04-282026-04-282025-10-28
审计意见(境内)标准无保留意见
TOP↑